-
Notifications
You must be signed in to change notification settings - Fork 8
/
SafeUseofOpioidsConcurrentPrescribingFHIR.json
586 lines (586 loc) · 30.7 KB
/
SafeUseofOpioidsConcurrentPrescribingFHIR.json
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
{
"resourceType": "Measure",
"id": "SafeUseofOpioidsConcurrentPrescribingFHIR",
"meta": {
"versionId": "14",
"lastUpdated": "2021-08-24T12:46:58.000-06:00",
"source": "#KGSxm0sO9TQeKT5m",
"profile": [ "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-measure-cqfm" ]
},
"language": "en",
"contained": [ {
"resourceType": "Library",
"id": "effective-data-requirements",
"extension": [ {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode",
"valueCoding": {
"system": "http://terminology.hl7.org/CodeSystem/medicationrequest-category",
"code": "discharge",
"display": "Discharge"
}
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SupplementalDataElementsFHIR4"
}, {
"url": "name",
"valueString": "SDE Sex"
}, {
"url": "statement",
"valueString": "define \"SDE Sex\":\n case\n when Patient.gender = 'male' then Code { code: 'M', system: 'http://hl7.org/fhir/v3/AdministrativeGender', display: 'Male' }\n when Patient.gender = 'female' then Code { code: 'F', system: 'http://hl7.org/fhir/v3/AdministrativeGender', display: 'Female' }\n else null\n end"
}, {
"url": "displaySequence",
"valueInteger": 0
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "SDE Sex"
}, {
"url": "statement",
"valueString": "define \"SDE Sex\":\n SDE.\"SDE Sex\""
}, {
"url": "displaySequence",
"valueInteger": 1
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "MATGlobalCommonFunctionsFHIR4"
}, {
"url": "name",
"valueString": "Inpatient Encounter"
}, {
"url": "statement",
"valueString": "define \"Inpatient Encounter\":\n [Encounter: \"Encounter Inpatient\"] EncounterInpatient\n \t\twhere EncounterInpatient.status = 'finished'\n \t\t and \"LengthInDays\"(EncounterInpatient.period) <= 120\n \t\t\tand EncounterInpatient.period ends during \"Measurement Period\""
}, {
"url": "displaySequence",
"valueInteger": 2
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "Inpatient Encounter with Age Greater than or Equal to 18"
}, {
"url": "statement",
"valueString": "define \"Inpatient Encounter with Age Greater than or Equal to 18\":\n Global.\"Inpatient Encounter\" EncounterInpatient\n where (AgeInYearsAt(date from start of EncounterInpatient.period)) >=18\n and EncounterInpatient.status = 'finished'"
}, {
"url": "displaySequence",
"valueInteger": 3
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "Numerator"
}, {
"url": "statement",
"valueString": "define \"Numerator\":\n /*Encounters of patients prescribed two or more opioids or an opioid and benzodiazepine at discharge.\n */\n ( ( \"Inpatient Encounter with Age Greater than or Equal to 18\" InpatientEncounter\n where (Count([\"MedicationRequest\": medication in \"Schedule II & III Opioid Medications\"] Opioids\n where Opioids.authoredOn during InpatientEncounter.period\n return distinct Opioids.medication\n )>= 2\n ))\n union ( \"Inpatient Encounter with Age Greater than or Equal to 18\" InpatientEncounter\n with [\"MedicationRequest\": medication in \"Schedule II & III Opioid Medications\"] OpioidsDischarge\n such that OpioidsDischarge.authoredOn during InpatientEncounter.period\n with [\"MedicationRequest\": medication in \"Schedule IV Benzodiazepines\"] BenzodiazepinesDischarge\n such that BenzodiazepinesDischarge.authoredOn during InpatientEncounter.period\n ))"
}, {
"url": "displaySequence",
"valueInteger": 4
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "Initial Population"
}, {
"url": "statement",
"valueString": "define \"Initial Population\":\n (\"Inpatient Encounter with Age Greater than or Equal to 18\" InpatientEncounter\n with ( [\"MedicationRequest\": \"Schedule II & III Opioid Medications\"]\n union [\"MedicationRequest\": \"Schedule IV Benzodiazepines\"] Medications\n where exists Medications.category C where FHIRHelpers.\"ToConcept\"(C) ~ Global.\"Discharge\" )OpioidOrBenzodiazepineDischargeMedication\n such that OpioidOrBenzodiazepineDischargeMedication.authoredOn during InpatientEncounter.period\n and OpioidOrBenzodiazepineDischargeMedication.status = 'active' and OpioidOrBenzodiazepineDischargeMedication.intent = 'plan')"
}, {
"url": "displaySequence",
"valueInteger": 5
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "Denominator"
}, {
"url": "statement",
"valueString": "define \"Denominator\":\n \"Initial Population\""
}, {
"url": "displaySequence",
"valueInteger": 6
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SupplementalDataElementsFHIR4"
}, {
"url": "name",
"valueString": "SDE Payer"
}, {
"url": "statement",
"valueString": "define \"SDE Payer\":\n [Coverage: type in \"Payer\"] Payer\n return {\n code: Payer.type,\n period: Payer.period\n }"
}, {
"url": "displaySequence",
"valueInteger": 7
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "SDE Payer"
}, {
"url": "statement",
"valueString": "define \"SDE Payer\":\n SDE.\"SDE Payer\""
}, {
"url": "displaySequence",
"valueInteger": 8
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SupplementalDataElementsFHIR4"
}, {
"url": "name",
"valueString": "SDE Ethnicity"
}, {
"url": "statement",
"valueString": "define \"SDE Ethnicity\":\n (flatten (\n Patient.extension Extension\n where Extension.url = 'http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity'\n return Extension.extension\n )) E\n where E.url = 'ombCategory'\n or E.url = 'detailed'\n return E.value as Coding"
}, {
"url": "displaySequence",
"valueInteger": 9
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "SDE Ethnicity"
}, {
"url": "statement",
"valueString": "define \"SDE Ethnicity\":\n SDE.\"SDE Ethnicity\""
}, {
"url": "displaySequence",
"valueInteger": 10
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "Denominator Exclusion"
}, {
"url": "statement",
"valueString": "define \"Denominator Exclusion\":\n /*Excludes encounters of patients with cancer or who are receiving palliative or hospice care at the time of the encounter*/\n (\"Inpatient Encounter with Age Greater than or Equal to 18\" InpatientEncounter\n where exists ( [\"Condition\": \"All Primary and Secondary Cancer\"] Cancer\n where Global.\"Prevalence Period\" (Cancer) overlaps InpatientEncounter.period\n )\n\n or exists ( [\"ServiceRequest\": \"Palliative or Hospice Care\"] PalliativeOrHospiceCareOrder\n where PalliativeOrHospiceCareOrder.authoredOn during InpatientEncounter.period\n and PalliativeOrHospiceCareOrder.intent = 'order'\n )\n or exists ( [\"Procedure\": \"Palliative or Hospice Care\"] PalliativeOrHospiceCarePerformed\n where Global.\"Normalize Interval\" ( PalliativeOrHospiceCarePerformed.performed) overlaps InpatientEncounter.period\n )\n or exists ( \"Inpatient Encounter with Age Greater than or Equal to 18\" InpatientEncounter\n where InpatientEncounter.hospitalization.dischargeDisposition in \"Discharge To Acute Care Facility\"\n or InpatientEncounter.hospitalization.dischargeDisposition in \"Hospice Care Referral or Admission\"\n or InpatientEncounter.hospitalization.dischargeDisposition in \"Patient Expired\"\n ) return InpatientEncounter )"
}, {
"url": "displaySequence",
"valueInteger": 11
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SupplementalDataElementsFHIR4"
}, {
"url": "name",
"valueString": "SDE Race"
}, {
"url": "statement",
"valueString": "define \"SDE Race\":\n (flatten (\n Patient.extension Extension\n where Extension.url = 'http://hl7.org/fhir/us/core/StructureDefinition/us-core-race'\n return Extension.extension\n )) E\n where E.url = 'ombCategory'\n or E.url = 'detailed'\n return E.value as Coding"
}, {
"url": "displaySequence",
"valueInteger": 12
} ]
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition",
"extension": [ {
"url": "libraryName",
"valueString": "SafeUseofOpioidsConcurrentPrescribingFHIR"
}, {
"url": "name",
"valueString": "SDE Race"
}, {
"url": "statement",
"valueString": "define \"SDE Race\":\n SDE.\"SDE Race\""
}, {
"url": "displaySequence",
"valueInteger": 13
} ]
} ],
"status": "active",
"type": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/library-type",
"code": "module-definition"
} ]
},
"relatedArtifact": [ {
"type": "depends-on",
"display": "Library SDE",
"resource": "http://ecqi.healthit.gov/ecqms/Library/SupplementalDataElementsFHIR4|2.0.000"
}, {
"type": "depends-on",
"display": "Library FHIRHelpers",
"resource": "http://ecqi.healthit.gov/ecqms/Library/FHIRHelpers|4.0.001"
}, {
"type": "depends-on",
"display": "Library Global",
"resource": "http://ecqi.healthit.gov/ecqms/Library/MATGlobalCommonFunctionsFHIR4|6.1.000"
}, {
"type": "depends-on",
"display": "Code system MedicationRequestCategory",
"resource": "http://terminology.hl7.org/CodeSystem/medicationrequest-category"
}, {
"type": "depends-on",
"display": "Value set Encounter Inpatient",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.307"
}, {
"type": "depends-on",
"display": "Value set Schedule II & III Opioid Medications",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.165"
}, {
"type": "depends-on",
"display": "Value set Schedule IV Benzodiazepines",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1"
}, {
"type": "depends-on",
"display": "Value set Payer",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591"
}, {
"type": "depends-on",
"display": "Value set All Primary and Secondary Cancer",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161"
}, {
"type": "depends-on",
"display": "Value set Palliative or Hospice Care",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1579"
}, {
"type": "depends-on",
"display": "Value set Discharge To Acute Care Facility",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.87"
}, {
"type": "depends-on",
"display": "Value set Hospice Care Referral or Admission",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365"
}, {
"type": "depends-on",
"display": "Value set Patient Expired",
"resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.309"
} ],
"parameter": [ {
"name": "Measurement Period",
"use": "in",
"min": 0,
"max": "1",
"type": "Period"
}, {
"name": "SDE Sex",
"use": "out",
"min": 0,
"max": "1",
"type": "Coding"
}, {
"name": "Numerator",
"use": "out",
"min": 0,
"max": "*",
"type": "Encounter"
}, {
"name": "Denominator",
"use": "out",
"min": 0,
"max": "*",
"type": "Encounter"
}, {
"name": "SDE Payer",
"use": "out",
"min": 0,
"max": "*",
"type": "Any"
}, {
"name": "Initial Population",
"use": "out",
"min": 0,
"max": "*",
"type": "Encounter"
}, {
"name": "SDE Ethnicity",
"use": "out",
"min": 0,
"max": "*",
"type": "Coding"
}, {
"name": "Denominator Exclusion",
"use": "out",
"min": 0,
"max": "*",
"type": "Encounter"
}, {
"name": "SDE Race",
"use": "out",
"min": 0,
"max": "*",
"type": "Coding"
} ],
"dataRequirement": [ {
"type": "Patient",
"profile": [ "http://hl7.org/fhir/StructureDefinition/Patient" ],
"mustSupport": [ "url", "extension", "value" ]
}, {
"type": "Encounter",
"profile": [ "http://hl7.org/fhir/StructureDefinition/Encounter" ],
"mustSupport": [ "type", "status", "period", "hospitalization", "hospitalization.dischargeDisposition" ],
"codeFilter": [ {
"path": "type",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.307"
} ]
}, {
"type": "MedicationRequest",
"profile": [ "http://hl7.org/fhir/StructureDefinition/MedicationRequest" ],
"mustSupport": [ "medication", "authoredOn" ],
"codeFilter": [ {
"path": "medication",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.165"
} ]
}, {
"type": "MedicationRequest",
"profile": [ "http://hl7.org/fhir/StructureDefinition/MedicationRequest" ],
"mustSupport": [ "medication", "authoredOn", "category" ],
"codeFilter": [ {
"path": "medication",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1"
} ]
}, {
"type": "Coverage",
"profile": [ "http://hl7.org/fhir/StructureDefinition/Coverage" ],
"mustSupport": [ "type", "period" ],
"codeFilter": [ {
"path": "type",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591"
} ]
}, {
"type": "Condition",
"profile": [ "http://hl7.org/fhir/StructureDefinition/Condition" ],
"mustSupport": [ "code" ],
"codeFilter": [ {
"path": "code",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161"
} ]
}, {
"type": "ServiceRequest",
"profile": [ "http://hl7.org/fhir/StructureDefinition/ServiceRequest" ],
"mustSupport": [ "code", "authoredOn", "intent" ],
"codeFilter": [ {
"path": "code",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1579"
} ]
}, {
"type": "Procedure",
"profile": [ "http://hl7.org/fhir/StructureDefinition/Procedure" ],
"mustSupport": [ "code", "performed" ],
"codeFilter": [ {
"path": "code",
"valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.600.1.1579"
} ]
} ]
} ],
"extension": [ {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-populationBasis",
"valueCode": "Encounter"
}, {
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-softwaresystem",
"valueReference": {
"reference": "Device/cqf-tooling"
}
}, {
"id": "effective-data-requirements",
"url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-effectiveDataRequirements",
"valueReference": {
"reference": "#effective-data-requirements"
}
} ],
"url": "http://ecqi.healthit.gov/ecqms/Measure/SafeUseofOpioidsConcurrentPrescribingFHIR",
"identifier": [ {
"use": "official",
"system": "http://hl7.org/fhir/cqi/ecqm/Measure/Identifier/guid",
"value": "25bf933d-60b1-4a30-b401-43ba7d3bfaa1"
}, {
"use": "official",
"system": "http://hl7.org/fhir/cqi/ecqm/Measure/Identifier/cms",
"value": "506FHIR"
}, {
"use": "official",
"system": "http://hl7.org/fhir/cqi/ecqm/Measure/Identifier/nqf",
"value": "3316e"
} ],
"version": "0.0.012",
"name": "SafeUseofOpioidsConcurrentPrescribingFHIR",
"title": "Safe Use of Opioids - Concurrent PrescribingFHIR",
"status": "draft",
"experimental": false,
"date": "2022-07-05T19:34:35-07:00",
"publisher": "Centers for Medicare & Medicaid Services (CMS)",
"contact": [ {
"telecom": [ {
"system": "url",
"value": "https://cms.gov"
} ]
} ],
"description": "Proportion of inpatient hospitalizations for patients 18 years of age and older prescribed, or continued on, two or more opioids or an opioid and benzodiazepine concurrently at discharge",
"purpose": "Unknown",
"copyright": "Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. Mathematica disclaims all liability for use or accuracy of any third party codes contained in the specifications.\n\nCPT(R) contained in the measure specifications is copyright 2004-2020 American Medical Association. LOINC(R) copyright 2004-2020 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2020 International Health Terminology Standards Development Organisation. ICD-10 copyright 2020 World Health Organization. All Rights Reserved.",
"effectivePeriod": {
"start": "2022-01-01",
"end": "2022-12-31"
},
"library": [ "http://ecqi.healthit.gov/ecqms/Library/SafeUseofOpioidsConcurrentPrescribingFHIR" ],
"disclaimer": "These performance measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. \n\nTHE MEASURES AND SPECIFICATION ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND. \n\nDue to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].",
"scoring": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-scoring",
"code": "proportion",
"display": "Proportion"
} ]
},
"type": [ {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-type",
"code": "process"
} ]
} ],
"rationale": "Unintentional opioid overdose fatalities have become a major public health concern in the United States (Rudd et al., 2016). Reducing the number of unintentional overdoses has become a priority for numerous federal organizations including, but not limited to, the Centers for Disease Control and Prevention (CDC), the Federal Interagency Workgroup for Opioid Adverse Drug Events, and the Substance Abuse and Mental Health Services Administration. \n\nConcurrent prescriptions of opioids or opioids and benzodiazepines places patients at a greater risk of unintentional overdose due to the increased risk of respiratory depression (Dowell, Haegerich, & Chou, 2016). An analysis of national prescribing patterns shows that more than half of patients who received an opioid prescription in 2009 had filled another opioid prescription within the previous 30 days (National Institute on Drug Abuse, 2011). Studies of multiple claims and prescription databases have shown that between 5%-15% of patients receive concurrent opioid prescriptions and 5%-20% of patients receive concurrent opioid and benzodiazepine prescriptions across various settings (Liu et al., 2013; Mack et al., 2015, Park et al., 2015). Patients who have multiple opioid prescriptions have an increased risk for overdose (Jena et al., 2014). Rates of fatal overdose are ten times higher in patients who are co-dispensed opioid analgesics and benzodiazepines than opioids alone (Dasgupta et al., 2015). The number of opioid overdose deaths involving benzodiazepines increased 14% on average each year from 2006 to 2011, while the number of opioid analgesic overdose deaths not involving benzodiazepines did not change significantly (Jones & McAninch, 2015). Furthermore, concurrent use of benzodiazepines with opioids was prevalent in 31%-51% of fatal overdoses (Dowell, Haegerich, & Chou, 2016). One study found that eliminating concurrent use of opioids and benzodiazepines could reduce the risk of opioid overdose-related ED and inpatient visits by 15% and potentially could have prevented an estimated 2,630 deaths related to opioid painkiller overdoses in 2015 (Sun et al., 2017). \n\nA study on The Opioid Safety Initiative in the Veterans Health Administration (VHA), which includes an opioid and benzodiazepine concurrent prescribing measure that this measure is based on, was associated with a decrease of 20.67% overall and 0.86% patients per month (781 patients per month) receiving concurrent benzodiazepine with an opioid among all adult VHA patients who filled outpatient opioid prescriptions from October 2012 to September 2014 (Lin et al., 2017).\n\nAdopting a measure that calculates the proportion of patients with two or more opioids or opioids and benzodiazepines concurrently has the potential to reduce preventable mortality and reduce the costs associated with adverse events related to opioid use by (1) encouraging providers to identify patients with concurrent prescriptions of opioids or opioids and benzodiazepines and (2) discouraging providers from prescribing two or more opioids or opioids and benzodiazepines concurrently.",
"clinicalRecommendationStatement": "The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain also recommends that:\n- \"Clinicians should avoid prescribing opioids and benzodiazepines concurrently whenever possible. Clinicians should communicate with others managing the patient to discuss the patient's needs, prioritize patient goals, weigh risks of concurrent benzodiazepine and opioid exposure, and coordinate care.\"\n- \"Clinicians should check the PDMP for concurrent controlled medications prescribed by other clinicians and should consider involving pharmacists and pain specialists as part of the management team when opioids are co-prescribed with other central nervous system depressants.\"\n- \"Experts emphasized that clinicians should communicate with mental health professionals managing the patient to discuss the patient's needs, prioritize patient goals, weigh risks of concurrent benzodiazepine and opioid exposure, and coordinate care.\"\n\nIn addition to the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, opioid prescribing guidelines issued by various state agencies and professional societies for various settings agree with the recommendation to avoid concurrently prescribing opioids (AAEM, WAMDG) and opioids and benzodiazepines (WAMDG, ASIPP, NYC DOHMH) whenever possible as the combination of these medications may potentiate opioid-induced respiratory depression.\n\nThe CDC Guideline for Prescribing Opioids for Chronic Pain (Dowell, 2016) also recommends that for patients found to have multiple opioid prescriptions clinicians should:\n- \"Discuss information from the PDMP with their patient and confirm that the patient is aware of the additional prescriptions.\"\n- \"Discuss safety concerns, including increased risk for respiratory depression and overdose, with patients found to be receiving opioids from more than one prescriber or receiving medications that increase risk when combined with opioids and consider offering naloxone.\"\n- \"Discuss safety concerns with other clinicians who are prescribing controlled substances for their patient. Ideally clinicians should first discuss concerns with their patient and inform him or her that they plan to coordinate care with the patient's other prescribers to improve the patient's safety.\"",
"improvementNotation": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-improvement-notation",
"code": "increase"
} ]
},
"guidance": "Clinician judgement, clinical appropriateness, or both may indicate concurrent prescribing of two unique opioids or an opioid and benzodiazepine is medically necessary, thus the measure is not expected to have a zero rate. \n\nInpatient hospitalizations with discharge medications of a new or continuing opioid or a new or continuing benzodiazepine prescription should be included in the initial population. \n\nInpatient hospitalizations with discharge medications of two or more new or continuing opioids or new or continuing opioid and benzodiazepine resulting in concurrent therapy at discharge should be included in the numerator. Each benzodiazepine and opioid included on the medication discharge list is considered a unique prescription.\n\nThis eCQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period.\n\nThis FHIR-based measure has been derived from the QDM-based measure: CMS506v4",
"group": [ {
"population": [ {
"id": "C9F8E7A2-F655-4E1B-AB93-3F6E31365B94",
"code": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-population",
"code": "initial-population",
"display": "Initial Population"
} ]
},
"criteria": {
"language": "text/cql.identifier",
"expression": "Initial Population"
}
}, {
"id": "848AB773-F370-448C-9696-4EA157BD5BC7",
"code": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-population",
"code": "denominator",
"display": "Denominator"
} ]
},
"criteria": {
"language": "text/cql.identifier",
"expression": "Denominator"
}
}, {
"id": "C839FCA5-7EE0-4CA8-BBA0-22E0DF69A428",
"code": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-population",
"code": "denominator-exclusion",
"display": "Denominator Exclusion"
} ]
},
"criteria": {
"language": "text/cql.identifier",
"expression": "Denominator Exclusion"
}
}, {
"id": "65399178-8207-47E4-A84F-88880EC73257",
"code": {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-population",
"code": "numerator",
"display": "Numerator"
} ]
},
"criteria": {
"language": "text/cql.identifier",
"expression": "Numerator"
}
} ]
} ],
"supplementalData": [ {
"id": "C9B4D981-3A73-41FB-807E-033E5D1DB2F1",
"usage": [ {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-data-usage",
"code": "supplemental-data"
} ]
} ],
"criteria": {
"language": "text/cql.identifier",
"expression": "SDE Ethnicity"
}
}, {
"id": "B4DC9811-5A52-4E5F-8888-4D0CDE78E931",
"usage": [ {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-data-usage",
"code": "supplemental-data"
} ]
} ],
"criteria": {
"language": "text/cql.identifier",
"expression": "SDE Payer"
}
}, {
"id": "19174E7F-3788-4596-AA73-A14143ABD2C6",
"usage": [ {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-data-usage",
"code": "supplemental-data"
} ]
} ],
"criteria": {
"language": "text/cql.identifier",
"expression": "SDE Race"
}
}, {
"id": "EE051572-7EF0-4DFA-86E1-696D712FB556",
"usage": [ {
"coding": [ {
"system": "http://terminology.hl7.org/CodeSystem/measure-data-usage",
"code": "supplemental-data"
} ]
} ],
"criteria": {
"language": "text/cql.identifier",
"expression": "SDE Sex"
}
} ]
}